Design and Optimization of Monoclonal Antibodies
A.Y. 2025/2026
Learning objectives
The purpose of this course is that participants gain knowledge on and understand:
- the principal biological features of mAbs used both in research and therapy
- the computational strategies, and their accuracy, for studying and modelling mAbs
- the main methods to produce mAbs, and to in silico and in vitro predict and validate their mechanisms of action (MoA)
- the safety and efficacy of monoclonal antibodies in vivo, with key examples of their application in the clinical setting
- the principal biological features of mAbs used both in research and therapy
- the computational strategies, and their accuracy, for studying and modelling mAbs
- the main methods to produce mAbs, and to in silico and in vitro predict and validate their mechanisms of action (MoA)
- the safety and efficacy of monoclonal antibodies in vivo, with key examples of their application in the clinical setting
Expected learning outcomes
At the end of the course, the student is expected:
- to know:
- the principal biological features of mAbs
- the application of the molecular and computational methods used in mAb analyses and design
-the different mechanisms of action of mAbs
- to critically evaluate:
- the pros and cons of in silico and in vitro approaches for mAb design and production
- the efficacy and safety of mAbs in clinical trials
to gain:
- the bases for deeply understanding development methods and applications of mAbs in research and therapy, with particular attention to scientific papers and/or clinical data and reports;
to obtain:
a multifaceted biological, bioinformatics and pharmacological knowledgebase useful for further student's personal study of this topic.
- to know:
- the principal biological features of mAbs
- the application of the molecular and computational methods used in mAb analyses and design
-the different mechanisms of action of mAbs
- to critically evaluate:
- the pros and cons of in silico and in vitro approaches for mAb design and production
- the efficacy and safety of mAbs in clinical trials
to gain:
- the bases for deeply understanding development methods and applications of mAbs in research and therapy, with particular attention to scientific papers and/or clinical data and reports;
to obtain:
a multifaceted biological, bioinformatics and pharmacological knowledgebase useful for further student's personal study of this topic.
Lesson period: Second semester
Assessment methods: Esame
Assessment result: voto verbalizzato in trentesimi
Single course
This course can be attended as a single course.
Course syllabus and organization
Single session
Responsible
Lesson period
Second semester
Prerequisites for admission
The course requires basic knowledge of biology, biochemical genetics, and molecular biology.
Assessment methods and Criteria
Module: In silico, molecular, and cellular approaches for the design of monoclonal antibodies
The exam will consist of a written test. Upon obtaining a passing grade, students will be admitted to an oral examination.
Module: Pharmacology of monoclonal antibodies
The exam will consist of a written test.
The exam will consist of a written test. Upon obtaining a passing grade, students will be admitted to an oral examination.
Module: Pharmacology of monoclonal antibodies
The exam will consist of a written test.
In silico, molecular and cellular approaches for monoclonal antibody design
Course syllabus
This module aims to provide students with fundamental concepts regarding the characterization of monoclonal antibodies (mAbs), as well as the computational and biotechnological strategies used in their design and production.
Introduction to proteins as therapeutic agents and the immune response
Structure of mAbs and their structural and functional features
Antigen-antibody binding and molecular recognition mechanisms
Computational strategies to design and/or optimize mAbs
Generation of mAbs: murine, chimeric, humanized, and human
Biotechnological synthesis of mAbs: from hybridomas to phage display
Antibody engineering: naked antibodies, conjugated antibodies, and antibody fragments
Application of mAbs in biological research
Introduction to proteins as therapeutic agents and the immune response
Structure of mAbs and their structural and functional features
Antigen-antibody binding and molecular recognition mechanisms
Computational strategies to design and/or optimize mAbs
Generation of mAbs: murine, chimeric, humanized, and human
Biotechnological synthesis of mAbs: from hybridomas to phage display
Antibody engineering: naked antibodies, conjugated antibodies, and antibody fragments
Application of mAbs in biological research
Teaching methods
Lectures. Each class session will last 2 hours. Through content presentation and interactive dialogue, students will critically learn the fundamentals of designing effective mAbs for therapeutic and/or research purposes. Active teaching methods will be used, such as Wooclap for assessment, self-evaluation, and knowledge consolidation, and flipped-classroom techniques to promote a critical approach to the subject.
Teaching Resources
Students will be provided with slides and scientific articles presented during the lectures. Recommended textbooks for further study:
"Biotechnological drugs, pharmacological and clinical aspects" by Vegeto, Maggi, Minghetti - CEA
"Cellular and Molecular Immunology" by Abbas, Lichtman - EDRA
"Biotechnological drugs, pharmacological and clinical aspects" by Vegeto, Maggi, Minghetti - CEA
"Cellular and Molecular Immunology" by Abbas, Lichtman - EDRA
Pharmacology of Monoclonal Antibodies
Course syllabus
This module aims to discuss the safety and efficacy of mAbs in vivo by studying their mechanisms of action and their clinical applications across various diseases.
Mechanism of action of monoclonal antibodies: cell-mediated cytotoxicity and complement-dependent cytotoxicity
Role of FC gamma receptor classes in the antibody response
Pharmacological basis for the loss of efficacy of monoclonal antibodies
Evaluation of clinical endpoints in oncology therapies using monoclonal antibodies
Clinical aspects of monoclonal antibody use in other chronic diseases
Mechanism of action of monoclonal antibodies: cell-mediated cytotoxicity and complement-dependent cytotoxicity
Role of FC gamma receptor classes in the antibody response
Pharmacological basis for the loss of efficacy of monoclonal antibodies
Evaluation of clinical endpoints in oncology therapies using monoclonal antibodies
Clinical aspects of monoclonal antibody use in other chronic diseases
Teaching methods
Lectures. Each class session will last 2 hours. Through content presentation and interactive dialogue, students will critically learn the fundamentals of designing effective mAbs for therapeutic and/or research purposes.
Teaching Resources
Students will be provided with slides and scientific articles presented during the lectures. Recommended textbooks for further study:
"Biotechnological drugs, pharmacological and clinical aspects" by Vegeto, Maggi, Minghetti - CEA
"Cellular and Molecular Immunology" by Abbas, Lichtman - EDRA
"Biotechnological drugs, pharmacological and clinical aspects" by Vegeto, Maggi, Minghetti - CEA
"Cellular and Molecular Immunology" by Abbas, Lichtman - EDRA
Modules or teaching units
In silico, molecular and cellular approaches for monoclonal antibody design
BIO/10 - BIOCHEMISTRY - University credits: 3
BIO/13 - EXPERIMENTAL BIOLOGY - University credits: 3
BIO/13 - EXPERIMENTAL BIOLOGY - University credits: 3
Lessons: 48 hours
Professors:
Eberini Ivano, Ferrari Veronica
Pharmacology of Monoclonal Antibodies
BIO/14 - PHARMACOLOGY - University credits: 3
Lessons: 24 hours
Professor:
Norata Giuseppe Danilo
Professor(s)
Reception:
On Mondays, Wednesdays and Fridays from 9 to 10 am and on appointment previously taken via Microsoft Teams or email
Microsoft Teams
Reception:
on appointment